buthionine sulfoximine glutathione The synthesis inhibitor synergistically enhanced melphalan activity against preclinical models of multiple myeloma investigate the effect of BSO on development of bovine embryos L-Buthionine sulfoximine
L Buthionine sulfoximine Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE DL Buthionine (S,R) sulfoximine C8H18N2O3S CID 119565 PubChem
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


